Apollon Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$699K Buy
14,503
+4,458
+44% +$208K 0.01% 731
2025
Q4
$487K Sell
10,045
-8,390
-46% -$416K 0.01% 845
2025
Q3
$870K Buy
18,435
+167
+0.9% +$8.06K 0.02% 621
2025
Q2
$883K Buy
18,268
+430
+2% +$22K 0.02% 586
2025
Q1
$989K Sell
17,838
-27
-0.2% -$1.46K 0.02% 511
2024
Q4
$862K Buy
17,865
+1,441
+9% +$73.3K 0.02% 564
2024
Q3
$946K Sell
16,424
-170
-1% -$9.18K 0.03% 510
2024
Q2
$805K Sell
16,594
-363
-2% -$17.5K 0.02% 531
2024
Q1
$824K Buy
16,957
+2,362
+16% +$115K 0.03% 528
2023
Q4
$726K Buy
14,595
+10,084
+224% +$493K 0.03% 557
2023
Q3
$242K Buy
+4,511
New +$241K 0.01% 770
2020
Q3
Sell
-192
Closed -$10K 608
2020
Q2
$10K Buy
+192
New +$9.33K 0.01% 502

Other funds holding SNY

Apollon Wealth Management's SNY Position: Q1 2026 in Review

Apollon Wealth Management increased its Sanofi (SNY) stake by 44% in Q1 2026, buying an estimated $208K and bringing the position to 14,503 shares worth $699K. The position accounts for 0.01% of the portfolio, ranked #731.

Apollon Wealth Management first reported a position in SNY in Q2 2020 and has held it in 12 quarters since. The position peaked at $989K in Q1 2025. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Apollon Wealth Management held 14,503 shares of Sanofi worth $699K as of Q1 2026.
  • Apollon Wealth Management bought 4,458 Sanofi shares in Q1 2026, an estimated $208K.
  • Sanofi made up 0.01% of Apollon Wealth Management's portfolio in Q1 2026, its #731 holding.
  • Apollon Wealth Management first reported a position in Sanofi in Q2 2020 and has held it in 12 quarters since.
  • Apollon Wealth Management's Sanofi position peaked at $989K in Q1 2025.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Apollon Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.